Non-Interventional Observational Study on the Influence of Pramipexole (PPX) on Sensory Symptoms of Restless Legs Syndrome (RLS).

Trial Profile

Non-Interventional Observational Study on the Influence of Pramipexole (PPX) on Sensory Symptoms of Restless Legs Syndrome (RLS).

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2014

At a glance

  • Drugs Pramipexole (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 31 Dec 2009 Actual patient number changed from 1498 to 1504 as reported by ClinicalTrials.gov.
    • 31 Dec 2009 Actual end date changed from Sep 2009 to October 2009 as reported by ClinicalTrials.gov.
    • 02 Dec 2009 Actual patient number changed from 1380 to 1498 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top